ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 87

Rheumatoid Arthritis Patients with Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity

Onno J. Arntz1, Bartijn C.H. Pieters1, Rogier Thurlings2, Peter M. van der Kraan1 and Fons A.J. van de Loo1, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Rheumatology, Radboud university medical center, Nijmegen, Netherlands

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:: Rheumatoid arthritis (RA) is an autoimmune inflammatory disease that mainly affects synovial joints. Most research on RA has focused on cytokines as main effectors in disease progression however, cell-cell communication involves a much broader scope of responses. Cells can release additionally extracellular vesicles (EVs) and an important role of these EVs has been postulated as important communicators between resident and inflammatory cells [1]. B-cells also release EVs that contain the B-cell receptor on their surface which is an immunoglobulin that binds and presents antigens to T-cells [2]. The presence of IgM-RF in seropositive RA patients clearly points to a role of B-cells and plasma cells in the pathogenesis of this disease. In this study we investigate the presence of RF-IgM on circulating EVs and the relation to the severity of RA.

Methods: EVs were isolated from platelet-free plasma of 41 RA patients and 24 healthy controls (HC) by size exclusion chromatography. We quantified the particle and protein concentration, using NanoSight particle tracking analysis and micro-BCA. Tender (TJC) and swollen joints (SJC) were assessed by physicians and the global patient visual analogue score (VAS) was determined by the patient. IgM-RF, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were determined by standard laboratory blood tests in our hospital. Disease activity score (DAS28) was calculated.

Results: RA and HC pEVs were not different in particle size, protein content and particle concentration (115nm, 49fg, 3.5×1010 and 108nm, 45fg, 3.8×1010, respectively). Between seronegative (RA-) and seropositive (RA+) patients, particle size, protein content per particle and amount of particles of pEVs were not statistically different (116nm, 39fg, 5.41010 and 114nm, 58fg, 1.8×1010, respectively). In plasma of 28 out of 41 RA patients IgM-RF was detectable, and in 13 out of these 28 RA+ IgM-RF was also detected on their isolated pEVs (RF+pEVs). In RA- patients we did not find any RF present on pEVs. When comparing disease parameters we found no differences between RA+ and RA- patients, except for increased ESR levels in RA+ patients. However, RA+ patients with RF+pEVs showed significant higher levels of CRP and ESR and also VAS and DAS28 were significant increased compared to RA+ patients without RF+pEVs.

Conclusion: This study shows for the first time the presence of IgM-RF on pEVs in a subset of RA+ patients with a more severe disease. The presence of RF+pEVs may point to a higher B-cell involvement in the disease process in these patients.


Disclosure: O. J. Arntz, None; B. C. H. Pieters, None; R. Thurlings, None; P. M. van der Kraan, None; F. A. J. van de Loo, None.

To cite this abstract in AMA style:

Arntz OJ, Pieters BCH, Thurlings R, van der Kraan PM, van de Loo FAJ. Rheumatoid Arthritis Patients with Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/rheumatoid-arthritis-patients-with-circulating-extracellular-vesicles-positive-for-igm-rheumatoid-factor-have-higher-disease-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-patients-with-circulating-extracellular-vesicles-positive-for-igm-rheumatoid-factor-have-higher-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology